Table III.
Patients characteristics on day 5: demographics and laboratory parameters
| Total (N = 32), M (IQR) | DVT-free (n = 27), M (IQR) | DVT (n = 5), M (IQR) | P value | |
|---|---|---|---|---|
| Age | 65.6 (±10.7) | 64.6 (±10.5) | 71.4 (±10.9) | .25 |
| Sex | ||||
| Female | 15 | 13 | 2 | – |
| Male | 17 | 14 | 3 | – |
| BMI (kg/m2) | 27.6 (±4.91) | 27.5 (±3.52) | 27.0 (±5.00) | 1 |
| CRP 0-3 mg/L | 112 (±71.2) | 105 (±72.7) | 150 (±53.9) | .15 |
| GFR >90 mL/min | 80.5 (±28.5) | 81.4 (±26.1) | 68.8 (±23.3) | .23 |
| D-dimer <500 ng/mL | 1398 (±1370) N = 23 | 1200 (±821) N = 18 | 2162 (±2364) N = 5 | .62 |
| DVT proximal | – | – | 2 (40) | – |
| DVT distal | – | – | 3 (60) | – |
| Preventive anticoagulation | – | – | 4 (80) | – |
| Therapeutic anticoagulation | – | – | 1 (20) | – |
| With signs and symptoms | – | – | 2 (40) | – |
| No signs and symptoms | – | – | 3 (60) | – |
BMI, Body mass index; CRP, C-reactive protein; DVT, deep venous thrombosis; GFR, glomerular filtration rate; IQR, interquartile range; M, median.
Data are presented as n (%) unless otherwise specified.